Back

A Scalable Saliva-based, Extraction-free RT-LAMP Protocol for SARS-Cov-2 Diagnosis

Asprino, P.; Bettoni, F.; Camargo, A.; Coelho, D.; Coppini, G.; Correa, I.; Freitas, E.; Inoue, L.; Kitajima, J. P.; Kuroki, M.; Masotti, C.; Marques, T.; Reis, A.; Reis, L. F.; Santos, B.; dos Santos, E.; Schlesinger, D.; Sena, C.; Spadaccini, T.; Taniguti, L.

2020-10-27 infectious diseases
10.1101/2020.10.27.20220541 medRxiv
Show abstract

I.Scalable, cost-effective screening methods are an essential tool to control SARS-CoV-2 spread. We have developed a straight saliva-based, RNA extraction-free, RT-LAMP test that is comparable to current nasopharyngeal swab RT-PCR tests in both sensitivity and specificity. Using a 2-step readout of fluorescence and melting-point curve analysis, the test is scalable to more than 30,000 tests per day with average turnaround time of less than 3 hours. The test was validated using samples from 244 symptomatic patients, and showed sensitivity of 78.9% (vs. 85.5% for nasopharyngeal swabs RT-PCR) and specificity of 100% (vs. 100% for nasopharyngeal swabs RT-PCR). Our method is therefore accurate, robust, time and cost effective and therefore can be used for screening of SARS-CoV-2.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.